The main pulmonary artery diameter, esophageal dilatation, and ILD score are independent risk factors for 5-year all-cause mortality in patients with connective tissue disease-associated PAH.

For patients who have pulmonary hypertension and heart failure with preserved ejection fraction (PH-HFpEF), treatment with levosimendan (Simdax; Tenax Therapeutics) can improve both pulmonary ...

Advanced imaging, like 4D-flow CMR, aids in understanding PA remodeling in different PH subtypes, offering non-invasive differentiation. PAH patients exhibit distinct PA flow characteristics, ...

Read before the New England Heart Association, Boston, April 5, 1933. Blumgart — Visiting Physician and Director of Research, Beth Israel Hospital. For record and address of author see "This Week's ...

IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. Chart of human respiratory and ...

Having had a front seat view to the struggles faced by patients suffering from poor circulation, two young medical doctors have partnered to make compression therapy more affordable and accessible to ...